Natural products as inhibitors of prostaglandin E2 and pro-inflammatory 5-lipoxygenase-derived lipid mediator biosynthesis
- PMID: 29454981
- DOI: 10.1016/j.biotechadv.2018.02.010
Natural products as inhibitors of prostaglandin E2 and pro-inflammatory 5-lipoxygenase-derived lipid mediator biosynthesis
Abstract
Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit prostanoid formation and represent prevalent therapeutics for treatment of inflammatory disorders. However, NSAIDs are afflicted with severe side effects, which might be circumvented by more selective suppression of pro-inflammatory eicosanoid biosynthesis. This concept led to dual inhibitors of microsomal prostaglandin E2 synthase (mPGES)-1 and 5-lipoxygenase that are crucial enzymes in the biosynthesis of pro-inflammatory prostaglandin E2 and leukotrienes. The potential of their dual inhibition in light of superior efficacy and safety is discussed. Focus is placed on natural products, for which direct inhibition of mPGES-1 and leukotriene biosynthesis has been confirmed.
Keywords: 5-Lipoxygenase; 5-Lipoxygenase-activating protein; Arachidonic acid; Cyclooxygenase; Eicosanoid; Leukotriene; Microsomal prostaglandin E(2) synthase-1; Natural product; Polypharmacology; Prostaglandin.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Discovery of a benzenesulfonamide-based dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase that favorably modulates lipid mediator biosynthesis in inflammation.Eur J Med Chem. 2018 Aug 5;156:815-830. doi: 10.1016/j.ejmech.2018.07.031. Epub 2018 Jul 25. Eur J Med Chem. 2018. PMID: 30053720
-
Rotational constriction of curcuminoids impacts 5-lipoxygenase and mPGES-1 inhibition and evokes a lipid mediator class switch in macrophages.Biochem Pharmacol. 2022 Sep;203:115202. doi: 10.1016/j.bcp.2022.115202. Epub 2022 Aug 3. Biochem Pharmacol. 2022. PMID: 35932797
-
Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin.Biochem Pharmacol. 2013 Aug 15;86(4):476-86. doi: 10.1016/j.bcp.2013.04.015. Epub 2013 Apr 24. Biochem Pharmacol. 2013. PMID: 23623753
-
Dual acting anti-inflammatory drugs: a reappraisal.Pharmacol Res. 2001 Dec;44(6):437-50. doi: 10.1006/phrs.2001.0872. Pharmacol Res. 2001. PMID: 11735348 Review.
-
Inhibitors of the microsomal prostaglandin E(2) synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs)--a critical review.Curr Med Chem. 2009;16(32):4274-96. doi: 10.2174/092986709789578178. Curr Med Chem. 2009. PMID: 19754418 Review.
Cited by
-
Optimized Encapsulation of the FLAP/PGES-1 Inhibitor BRP-187 in PVA-Stabilized PLGA Nanoparticles Using Microfluidics.Polymers (Basel). 2020 Nov 20;12(11):2751. doi: 10.3390/polym12112751. Polymers (Basel). 2020. PMID: 33233853 Free PMC article.
-
RNAseq analysis of treatment-dependent signaling changes during inflammation in a mouse cutaneous wound healing model.BMC Genomics. 2021 Nov 25;22(1):854. doi: 10.1186/s12864-021-08083-2. BMC Genomics. 2021. PMID: 34823472 Free PMC article.
-
Encapsulation of the dual FLAP/mPEGS-1 inhibitor BRP-187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity.J Nanobiotechnology. 2020 May 14;18(1):73. doi: 10.1186/s12951-020-00620-7. J Nanobiotechnology. 2020. PMID: 32408877 Free PMC article.
-
Controlled Release of the α-Tocopherol-Derived Metabolite α-13'-Carboxychromanol from Bacterial Nanocellulose Wound Cover Improves Wound Healing.Nanomaterials (Basel). 2021 Jul 28;11(8):1939. doi: 10.3390/nano11081939. Nanomaterials (Basel). 2021. PMID: 34443772 Free PMC article.
-
Design and synthesis of new dihydropyrimidine/sulphonamide hybrids as promising anti-inflammatory agents via dual mPGES-1/5-LOX inhibition.Front Chem. 2024 May 10;12:1387923. doi: 10.3389/fchem.2024.1387923. eCollection 2024. Front Chem. 2024. PMID: 38800576 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
